Literature DB >> 16100526

The regulation of veratridine-stimulated electrogenic ion transport in mouse colon by neuropeptide Y (NPY), Y1 and Y2 receptors.

Niall P Hyland1, Helen M Cox.   

Abstract

1 Neuropeptide Y (NPY) is a prominent enteric neuropeptide with prolonged antisecretory effects in mammalian intestine. Veratridine depolarises neurons consequently causing epithelial anion secretion across mouse colon mucosa. Our aim was to characterise functionally, veratridine-stimulated mucosal responses and to determine the roles for NPY, Y(1), and Y(2) receptors in modulating these neurogenic effects. 2 Colon mucosae (with intact submucous innervation) from wild-type mice (+/+) and knockouts lacking either NPY (NPY-/-), Y(1)-/- or Y(2)-/- were placed in Ussing chambers and voltage clamped at 0 mV. Veratridine-stimulated short-circuit current (I(sc)) responses in +/+, Y(1) or Y(2) antagonist pretreated +/+ colon, Y(1)-/- and NPY-/- colon were insensitive to cholinergic blockade by atropine (At; 1 microM) and hexamethonium (Hex; 10 microM). Tetrodotoxin (TTX, 100 nM) abolished veratridine responses, but had no effect upon carbachol (CCh) or vasoactive intestinal polypeptide (VIP)-induced secretory responses. 3 To establish the functional roles for Y(1) and Y(2) receptors, +/+ tissues were pretreated with either the Y(1) or Y(2) receptor antagonist (BIBO3304 (300 nM) or BIIE0246 (1 microM), respectively) and veratridine responses were compared with those from Y(1)-/- or Y(2)-/- colon. Neither BIBO3304 nor Y(1)-/- altered veratridine-induced secretion, but Y(1) agonist responses were abolished in both preparations. In contrast, the Y(2) antagonist BIIE0246 significantly amplified veratridine responses in +/+ mucosa. Unexpectedly, NPY-/- colon exhibited significantly attenuated veratridine responses (between 1 and 5 min). 4 We demonstrate that electrogenic veratridine responses in mouse colon are noncholinergic and that NPY can act directly upon epithelia, a Y(1) receptor effect. The enhanced veratridine response observed in +/+ tissue following BIIE0246, indicates that Y(2) receptors are located on submucosal neurons and that their activation by NPY will inhibit enteric noncholinergic secretory neurotransmission. 5 We also demonstrate Y(1) and Y(2) receptor-mediated antisecretory tone in +/+ colon and show selective loss of each in Y(1) and Y(2) null colon respectively. In NPY-/- tissue, only Y(1)-mediated tone was present, this presumably being mediated by endogenous endocrine peptide YY. Y(2) tone was absent from NPY-/- (and Y(2)-/-) colon and we conclude that NPY activation of neuronal Y(2) receptors attenuates secretory neurotransmission thereby providing an absorptive electrolyte tone in isolated colon.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16100526      PMCID: PMC1751203          DOI: 10.1038/sj.bjp.0706368

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  42 in total

Review 1.  Types of neurons in the enteric nervous system.

Authors:  J B Furness
Journal:  J Auton Nerv Syst       Date:  2000-07-03

2.  Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release.

Authors:  P J King; G Williams; H Doods; P S Widdowson
Journal:  Eur J Pharmacol       Date:  2000-05-12       Impact factor: 4.432

3.  BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist.

Authors:  H Doods; W Gaida; H A Wieland; H Dollinger; G Schnorrenberg; F Esser; W Engel; W Eberlein; K Rudolf
Journal:  Eur J Pharmacol       Date:  1999-11-19       Impact factor: 4.432

4.  Effects of the neuropeptide Y Y(2) receptor antagonist BIIE0246 on presynaptic inhibition by neuropeptide Y in rat hippocampal slices.

Authors:  T Weiser; H A Wieland; H N Doods
Journal:  Eur J Pharmacol       Date:  2000-09-15       Impact factor: 4.432

5.  Neuropeptide Y, Y1, Y2 and Y4 receptors mediate Y agonist responses in isolated human colon mucosa.

Authors:  Helen M Cox; Iain R Tough
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

Review 6.  Distribution of pancreatic polypeptide and peptide YY.

Authors:  Eva Ekblad; Frank Sundler
Journal:  Peptides       Date:  2002-02       Impact factor: 3.750

7.  Selective inhibition of neuropeptide Y Y1 receptors by BIBP3226 in rat and human epithelial preparations.

Authors:  I R Tough; H M Cox
Journal:  Eur J Pharmacol       Date:  1996-08-22       Impact factor: 4.432

8.  Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.

Authors:  Rickard E Malmström; Jon N Lundberg; Eddie Weitzberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2001-12-18       Impact factor: 3.000

9.  Effects of a selective neuropeptide Y Y2 receptor antagonist, BIIE0246, on Y2 receptors at peripheral neuroeffector junctions.

Authors:  M A Smith-White; T A Hardy; J A Brock; E K Potter
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

10.  Multiple Y receptors mediate pancreatic polypeptide responses in mouse colon mucosa.

Authors:  H M Cox; E L Pollock; I R Tough; H Herzog
Journal:  Peptides       Date:  2001-03       Impact factor: 3.750

View more
  17 in total

1.  Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome.

Authors:  Marta Zielińska; Agata Jarmuż; Andrzej Wasilewski; Gerta Cami-Kobeci; Stephen Husbands; Jakub Fichna
Journal:  Pharmacol Rep       Date:  2016-12-05       Impact factor: 3.024

2.  Enteric glial activity regulates secretomotor function in the mouse colon but does not acutely affect gut permeability.

Authors:  Vladimir Grubišić; Brian D Gulbransen
Journal:  J Physiol       Date:  2017-02-22       Impact factor: 5.182

3.  Ileitis alters neuronal and enteroendocrine signalling in guinea pig distal colon.

Authors:  Jennifer R O'Hara; Alan E Lomax; Gary M Mawe; Keith A Sharkey
Journal:  Gut       Date:  2006-08-24       Impact factor: 23.059

4.  A novel role for the metabotropic glutamate receptor-7: modulation of faecal water content and colonic electrolyte transport in the mouse.

Authors:  M Julio-Pieper; N P Hyland; J A Bravo; T G Dinan; J F Cryan
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

5.  Peptide Tyrosine Tyrosine 3-36 Reduces Meal Size and Activates the Enteric Neurons in Male Sprague-Dawley Rats.

Authors:  Kayla D Newman; Thaer R Mhalhal; Martha C Washington; John C Heath; Ayman I Sayegh
Journal:  Dig Dis Sci       Date:  2017-10-13       Impact factor: 3.199

6.  Myosin light chain kinase inhibition: correction of increased intestinal epithelial permeability in vitro.

Authors:  Linda M Feighery; Sean W Cochrane; Teresa Quinn; Alan W Baird; Daniel O'Toole; Sian-Eleri Owens; Diarmuid O'Donoghue; Randall J Mrsny; David J Brayden
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

7.  Alterations to enteric neural signaling underlie secretory abnormalities of the ileum in experimental colitis in the guinea pig.

Authors:  Ian M Hons; Joshua E Burda; John R Grider; Gary M Mawe; Keith A Sharkey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-02-12       Impact factor: 4.052

8.  Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice.

Authors:  Lixin Wang; Guillaume Gourcerol; Pu-Qing Yuan; S Vincent Wu; Mulugeta Million; Muriel Larauche; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11-05       Impact factor: 4.052

9.  Properties of cholinergic and non-cholinergic submucosal neurons along the mouse colon.

Authors:  Jaime Pei Pei Foong; Iain R Tough; Helen M Cox; Joel C Bornstein
Journal:  J Physiol       Date:  2013-12-16       Impact factor: 5.182

10.  Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century.

Authors:  Magdy El-Salhy; Tanisa Patcharatrakul; Sutep Gonlachanvit
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.